New Leaf Biopharma Opportunities II, L.P.

Insider Reports History

Entity
Company
Location
420 Lexington Avenue, Suite 408, New York, New York
Signature
New Leaf Ventures III, L.P., By: New Leaf Venture Associates III, L.P., its general partner, By: New Leaf Venture Management III, L.L.C., its general partner, By: /s/ Craig Slutzkin, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Leaf Biopharma Opportunities II, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Harpoon Therapeutics, Inc. Director, 10%+ Owner 8.000% Series A Redeemable Preferred Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 Mar 11, 2024 Indirect

Insider Reports Filed by New Leaf Biopharma Opportunities II, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HARP Harpoon Therapeutics, Inc. Mar 11, 2024 6 $0 4 Mar 11, 2024 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Oct 25, 2023 4 $0 4 Oct 27, 2023 10%+ Owner
HARP Harpoon Therapeutics, Inc. Mar 23, 2023 0 $0 3 Mar 27, 2023 10%+ Owner